Advertisement

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Advertisement

Advertisement

Apr

01

Today In Oncology

Molecular Test Doubles Detection of Bile Duct Cancer

‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?

Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence

Risk of Subsequent Cancer in Solid Organ Transplant Recipients With Pretransplant Cancer History

Elinzanetant May Reduce Side Effects of Endocrine Therapy Among Patients With Breast Cancer

Advertisement

© 2026 HSP News Service, L.L.C.